As of Jun 15
| +0.05 / +0.87%|
The 6 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 15.00, with a high estimate of 23.00 and a low estimate of 5.50. The median estimate represents a +158.62% increase from the last price of 5.80.
The current consensus among 7 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.